OUTCOME FOLLOWING STANDARDIZED 185 MBQ DOSE I-131 THERAPY FOR GRAVES-DISEASE

被引:55
作者
WATSON, AB
BROWNLIE, BEW
FRAMPTON, CM
TURNER, JG
ROGERS, TGH
机构
[1] CHRISTCHURCH HOSP,DEPT NUCL MED,CHRISTCHURCH,NEW ZEALAND
[2] CHRISTCHURCH HOSP,DEPT MED PHYS,CHRISTCHURCH,NEW ZEALAND
[3] CHRISTCHURCH CLIN SCH,DEPT COMMUNITY HLTH,CHRISTCHURCH,NEW ZEALAND
关键词
D O I
10.1111/j.1365-2265.1988.tb03683.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:487 / 496
页数:10
相关论文
共 21 条
[1]   HLA-DR3 AND DRW6 - PROGNOSTIC FACTORS FOR THE INCIDENCE OF HYPOTHYROIDISM IN GRAVES-DISEASE AFTER RADIOIODINE TREATMENT [J].
ALTHAUS, B ;
STAUB, JJ ;
NERI, TM ;
HAUENSTEIN, M ;
MULLERBRAND, J ;
BERGER, W ;
FARID, NR .
ACTA ENDOCRINOLOGICA, 1986, 113 (03) :323-328
[2]   THYROID VASCULARITY AND TRAPPING FUNCTION - ANALYSIS OF VERY EARLY THYROIDAL TECHNETIUM UPTAKE [J].
ARMSTRONG, DI ;
ROGERS, TGH ;
BROWNLIE, BEW ;
TURNER, JG .
INTERNATIONAL JOURNAL OF NUCLEAR MEDICINE & BIOLOGY, 1976, 3 (02) :65-70
[3]  
BARANDES M, 1973, J NUCL MED, V14, P379
[4]   GRAVES-DISEASE IN MALE - REVIEW OF 241 CASES TREATED WITH AN INDIVIDUALLY CALCULATED DOSE OF SODIUM IODIDE I-131 [J].
BLAHD, WH ;
HAYS, MT .
ARCHIVES OF INTERNAL MEDICINE, 1972, 129 (01) :33-+
[5]   I-131 TREATMENT OF DIFFUSE AND NODULAR TOXIC GOITER WITH OR WITHOUT ANTITHYROID AGENTS [J].
BLIDDAL, H ;
HANSEN, JM ;
ROGOWSKI, P ;
JOHANSEN, K ;
FRIIS, T ;
SIERSBAEKNIELSEN, K .
ACTA ENDOCRINOLOGICA, 1982, 99 (04) :517-521
[6]   RESULTS OF LITHIUM-I-131 TREATMENT OF THYROTOXICOSIS [J].
BROWNLIE, BEW ;
TURNER, JG ;
OVENDEN, BM ;
ROGERS, TGH .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1979, 2 (03) :303-304
[7]  
DIXON WJ, 1985, BMPD STATISTICAL SOF
[8]  
DONALD RA, 1973, NEW ZEAL MED J, V78, P204
[9]   VARIABILITY OF HUMAN THYROID CHARACTERISTICS AND ESTIMATES OF DOSE FROM INGESTED I-131 [J].
DUNNING, DE ;
SCHWARZ, G .
HEALTH PHYSICS, 1981, 40 (05) :661-675
[10]   LONG-TERM RESULTS FROM GRADED LOW-DOSE RADIOACTIVE IODINE THERAPY FOR THYROTOXICOSIS [J].
GOOLDEN, AWG ;
STEWART, JSW .
CLINICAL ENDOCRINOLOGY, 1986, 24 (02) :217-222